New research uncovers a connection between SSRI use and apathy in Parkinson’s disease (PD):
🔹 Key findings:
-38% of participants met clinical criteria for apathy, 28% for depression.
-SRI use was linked to higher apathy scores in PD.
-Education, cognition, and depressive symptoms also predicted apathy.
🔹 Why it matters:
-SSRIs may affect dopamine systems, worsening motivation in PD.
-Switching antidepressants could be a strategy to treat apathy in PD.
🌟 Takeaway: Careful antidepressant selection is crucial in managing PD symptoms.
#ParkinsonsResearch#MentalHealth#Neurology
Read More: journals.sagepub.com/doi/10.1177/08919887241254471?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub 0pubmed